The partnership focuses on the development and commercialization of specialized medical aesthetic tools, including skin boosters, cosmeceuticals, and advanced medical devices. By leveraging HIGHER Corporation’s global network of physicians and its flagship HILO WAVE® platform, the companies intend to create a seamless ecosystem where clinical aftercare products are distributed directly through professional medical channels.
In section Releases
Amorepacific Targets Medical Aesthetics with HIGHER Corp Partnership
Amorepacific Holdings has inked a strategic investment deal with HIGHER Corporation to fuse its established skin science research with professional medical aesthetics. The collaboration aims to bridge clinical treatments and daily home-care routines, targeting a global market hungry for integrated, science-backed beauty solutions.
Sangmok Lee, CEO of Amorepacific Holdings, emphasized the goal of merging skin science with medical technology to deliver novel consumer experiences. In Yong Kim, CEO of HIGHER Corporation, noted that the move reinforces the company’s commitment to science-driven innovation, specifically utilizing the proprietary DHC® technology found in its HILO WAVE® range. This joint effort marks a shift for Amorepacific as it seeks to expand its footprint beyond traditional cosmetics into the high-growth sector of medical-grade skin remodeling.
Comments (0)
No comments yet. Be the first!